
    
      Primary & booster vaccination study to evaluate the immuno,reacto & safety of 3 diff.
      formulations of GSKBio'combined Haemophilus influenzae typeb-meningococcal serogroups C &
      Y-conjugate vaccine & one formulation of GSKBio' Haemophilus influenzae typeb-meningococcal
      serogroup C conjugate vaccine each given concomitantly With Infanrix penta (DTaP-IPV-HepB
      vaccine), vs Meningitec meningococcal SerogroupC conj.vaccine) given concomitantly With
      Infanrix hexa (DTaP-IPV-HepB-Hib vaccine) in infants according a 2-3-4 mth schedule
    
  